Insulet Corp.

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum on Thursday, September 24, 2026, at 12:30 p.m. (Eastern Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About.

California State Teachers Retirement System grew its holdings in shares of Insulet Corporation (NASDAQ: PODD) by 13,901.9% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,562,256 shares of the medical instruments supplier's stock after acquiring an additional 14,458,254

Amundi increased its holdings in shares of Insulet Corporation (NASDAQ: PODD) by 13.6% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 507,847 shares of the medical instruments supplier's stock after acquiring an additional 60,929 shares during the quarter. Amundi

Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript